P & G Health Q4 FY26 results (Jan–Mar 2026) and concall

Healthcare · Concall AI · Call held 18 Jun 2026

Company page: P & G Health share price, financials & guidance record

P & G Health Ltd reported a strong fiscal year 2026, with sales growing 16% to nearly ₹1400 crore and PAT increasing 30% to ₹327 crores. This performance was driven by a robust integrated growth strategy, including successful new product launches and expanded distribution. The company emphasized its focus on superiority, productivity, and constructive disruption to sustain balanced growth.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q4 FY26: revenue up 19.0%, net profit up 55.7% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26
Revenue	313	310	311	339	325 +4%	374 +21%	370 +19%
Expenses	199	186	230	248	205	263	235
EBITDA	114	123	81	90	120 +5%	110 −11%	136 +68%
Margin	36%	40%	26%	27%	37%	30%	37%
Other income	3	4	3	4	5	4	4
Interest	0	0	0	0	0	0	0
Depreciation	6	6	5	5	6	6	6
Profit before tax	111	122	79	89	119 +7%	109 −11%	133 +68%
Tax rate	26%	25%	22%	25%	26%	29%	29%
Net profit	82	91	61	66	89 +9%	78 −14%	95 +56%
EPS	49.60	54.76	36.86	39.87	53.34	46.74	56.99

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Healthcare earnings calls